Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
1.8.3 Objective 3
1.8.4 Objective 4
1.9 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Meningococcal Vaccines Market Variables, Trends & Scope
3.1 Key Opportunities Prioritized
3.2 Product Pipeline Analysis
3.3 Regulatory Framework
3.3.1 North America
3.3.2 Europe
3.3.3 Asia Pacific
3.3.4 Latin America
3.3.5 Middle East And Africa
3.4 Market Driver Analysis
3.4.1 Rising Incidence Of Meningitis Disease
3.4.2 Rising R&D In Meningococcal Vaccines
3.4.3 Increasing Immunization Programs And Government Initiatives
3.4.4 Growing Support By Healthcare Services In Providing Low-Cost Meningococcal Vaccine
3.5 Market Restraint Analysis
3.5.1 High Cost Associated With Storage And Supply Of Vaccines
3.6 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.7 Porter’s Five Forces Analysis
3.8 Major Deals And Strategic Alliances Analysis
3.8.1 New Product Launch
3.8.2 Mergers And Acquisitions
3.8.3 Expansion
3.8.4 Partnerships
3.8.5 Marketing & Promotions
3.8.6 Market Entry Strategies
Chapter 4 Meningococcal Vaccines Market: Segment Analysis, By Type, 2016 - 2027 (USD Million)
4.1 Definition And Scope
4.2 Type Market Share Analysis, 2019 & 2027
4.3 Segment Dashboard
4.4 Global Meningococcal Vaccines Market, By Type, 2016 To 2027
4.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027
4.5.1 Bivalent
4.5.1.1 Bivalent Market Estimates And Forecast, 2016 - 2027 (USD Million)
4.5.2 Quadrivalent
4.5.2.1 Quadrivalent Market Estimates And Forecast, 2016 - 2027 (USD Million)
4.5.3 Others
4.5.3.1 Others Market Estimates And Forecast, 2016 - 2027 (USD Million)
Chapter 5 Meningococcal Vaccines Market: Segment Analysis, By Brand, 2016 - 2027 (USD Million)
5.1 Definition And Scope
5.2 Brand Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Meningococcal Vaccines Market, By Brand, 2016 To 2027
5.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027
5.5.1 Menactra
5.5.1.1 Menactra Market Estimates And Forecast, 2016 - 2027 (USD Million)
5.5.2 Menveo
5.5.2.1 Menveo Market Estimates And Forecast, 2016 - 2027 (USD Million)
5.5.3 Nimenrix
5.5.3.1 Nimenrix Market Estimates And Forecast, 2016 - 2027 (USD Million)
5.5.4 Trumenba
5.5.4.1 Trumenba Market Estimates And Forecast, 2016 - 2027 (USD Million)
5.5.5 Bexsero
5.5.5.1 Bexsero Market Estimates And Forecast, 2016 - 2027 (USD Million)
5.5.6 Others
5.5.6.1 Others Market Estimates And Forecast, 2016 - 2027 (USD Million)
Chapter 6 Meningococcal Vaccines Market: Segment Analysis, By Age Group, 2016 - 2027 (USD Million)
6.1 Definition And Scope
6.2 Age Group Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Meningococcal Vaccines Market, By Age Group, 2016 To 2027
6.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027
6.5.1 Infants (0-2 Years)
6.5.1.1 Infants (0-2 Years) Market Estimates And Forecast, 2016 - 2027 (USD Million)
6.5.2 Children And Adults (2 Years And Above)
6.5.2.1 Children And Adults (2 Years And Above) Market Estimates And Forecast, 2016 - 2027 (USD Million)
Chapter 7 Meningococcal Vaccines Market: Segment Analysis, By Region, 2016 - 2027 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2019 & 2027
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Regional Market Share And Leading Players, 2019
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East And Africa
7.6 Swot Analysis
7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East And Africa
7.7 Market Size & Forecasts And Trend Analyses, 2016 To 2027
7.7.1 North America
7.7.1.1 North America Market Estimates And Forecasts, 2016 - 2027 (USD Million)
7.7.1.2 The U.S.
7.7.1.2.1 U.S. Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.1.3 Canada
7.7.1.3.1 Canada Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2 Europe
7.7.2.1 Europe Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2.2 Germany
7.7.2.2.1 Germany Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2.3 The U.K.
7.7.2.3.1 The U.K. Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2.4 France
7.7.2.4.1 France Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2.5 Spain
7.7.2.5.1 Spain Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2.6 Italy
7.7.2.6.1 Italy Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.2.7 Russia
7.7.2.7.1 Russia Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3 Asia Pacific
7.7.3.1 Asia Pacific Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3.2 Japan
7.7.3.2.1 Japan Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3.3 China
7.7.3.3.1 China Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3.4 India
7.7.3.4.1 India Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3.5 South Korea
7.7.3.5.1 South Korea Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3.6 Australia
7.7.3.6.1 Australia Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.3.7singapore
7.7.3.7.1 Singapore Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.4 Latin America
7.7.4.1 Latin America Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.4.2 Brazil
7.7.4.2.1 Brazil Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.4.3 Mexico
7.7.4.3.1 Mexico Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.4.4 Argentina
7.7.4.4.1 Argentina Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.5 Middle East & Africa
7.7.5.1 Middle-East And Africa Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.5.2 South Africa
7.7.5.2.1 South Africa Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.5.3 Saudi Arabia
7.7.5.3.1 Saudi Arabia Market Estimate And Forecasts, 2016 - 2027 (USD Million)
7.7.5.4 UAE
7.7.5.4.1 UAE Market Estimate And Forecasts, 2016 - 2027 (USD Million)
Chapter 8 Competitive Landscape
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.1.1 Ansoff Matrix
8.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
8.1.3 Innovators
8.2 Vendor Landscape
8.2.1 List Of Key Distributors And Channel Partners
8.2.2 Key Company Market Share Analysis, 2019
8.3 Public Companies
8.3.1 Company Market Position Analysis
8.3.2 Competitive Dashboard Analysis
8.4 Private Companies
8.4.1 Key Emerging Companies /Technology Disruptors/Innovators
8.4.2 Regional Network Map
8.5 Company Profile
8.5.1 Sanofi
8.5.1.1 Company Overview
8.5.1.2 Financial Performance
8.5.1.3 Product Benchmarking
8.5.1.4 Strategic Initiatives
8.5.2 Merck & Co., Inc.
8.5.2.1company Overview
8.5.2.2 Financial Performance
8.5.2.3 Product Benchmarking
8.5.2.4 Strategic Initiatives
8.5.3 GlaxoSmithKline Plc.
8.5.3.1company Overview
8.5.3.2 Financial Performance
8.5.3.3 Product Benchmarking
8.5.3.4 Strategic Initiatives
8.5.4 Serum Institute Of India Pvt. Ltd.
8.5.4.1 Company Overview
8.5.4.2 Product Benchmarking
8.5.4.3 Strategic Initiatives
8.5.5 Pfizer Inc.
8.5.5.1 Company Overview
8.5.5.2 Financial Performance
8.5.5.3 Product Benchmarking
8.5.5.4 Strategic Initiatives



List of Tables



Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Product pipeline
Table 4 CDC Vaccine Price List
Table 5 List of key emerging companies /technology disruptors/innovators
Table 6 America Meningococcal Vaccines Market, By Country, 2016 - 2027 (USD Million)
Table 7 North America Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 8 North America Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 9 North America Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 10 The U.S. Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 11 The U.S. Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 12 The U.S. Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 13 Canada Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 14 Canada Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 15 Canada Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 16 Europe Meningococcal Vaccines Market, By Country, 2016 - 2027 (USD Million)
Table 17 Europe Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 18 Europe Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 19 Europe Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 20 Germany Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 21 Germany Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table22 Germany Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 23 The U.K. Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 24 The U.K. Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 25 The U.K. Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 26 France Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 27 France Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 28 France Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 29 Italy Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 30 Italy Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 31 Italy Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 32 Spain Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 33 Spain Meningococcal VaccinesMarket, By Brand, 2016 - 2027 (USD Million)
Table 34 Spain Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 35 Russia Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 36 Russia Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 37 Russia Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 39 Asia Pacific Meningococcal Vaccines Market, By Country, 2016 - 2027 (USD Million)
Table 40 Asia Pacific Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 41 Asia Pacific Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 42 Asia Pacific Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 43 Japan Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 44 Japan Meningococcal Vaccines Market, By Brand 2016 - 2027 (USD Million)
Table 45 Japan Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 46 China Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 47 China Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 48 China Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 49 India Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 50 India Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 51 India Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 52 Australia Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 53 Australia Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 54 Australia Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 55 Singapore Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 56 Singapore Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 57 Singapore Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 58 South Korea Meningococcal Vaccines Market, By Type 2016 - 2027 (USD Million)
Table 59 South Korea Meningococcal VaccinesMarket, By Brand, 2016 - 2027 (USD Million)
Table 60 South Korea Meningococcal VaccinesMarket, By Age Group, 2016 - 2027 (USD Million)
Table 61 Latin America Meningococcal Vaccines Market, By Country, 2016 - 2027 (USD Million)
Table 62 Latin America Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 63 Latin America Meningococcal VaccinesMarket, By Brand, 2016 - 2027 (USD Million)
Table 64 Latin America Meningococcal VaccinesMarket, By Age Group, 2016 - 2027 (USD Million)
Table 65 Brazil Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 66 Brazil Meningococcal Vaccines Market, By Brand 2016 - 2027 (USD Million)
Table 67 Brazil Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 68 Mexico Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 69 Mexico Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 70 Mexico Meningococcal VaccinesMarket, By Age Group, 2016 - 2027 (USD Million)
Table 71 Argentina Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 72 Argentina Meningococcal VaccinesMarket, By Brand, 2016 - 2027 (USD Million)
Table 73 Argentina Meningococcal VaccinesMarket, By Age Group, 2016 - 2027 (USD Million)
Table 74 Middle East & Africa Meningococcal Vaccines Market, By Country, 2016 - 2027 (USD Million)
Table 75 Middle East & Africa Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 76 Middle East & Africa Meningococcal VaccinesMarket, By Brand, 2016 - 2027 (USD Million)
Table 77 Middle East & Africa Meningococcal VaccinesMarket, By Age Group, 2016 - 2027 (USD Million)
Table 78 Saudi Arabia Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 79 Saudi Arabia Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 80 Saudi Arabia Meningococcal VaccinesMarket, By Age Group, 2016 - 2027 (USD Million)
Table 81 South Africa Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 82 South Africa Meningococcal VaccinesMarket, By Brand, 2016 - 2027 (USD Million)
Table 83 South Africa Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)
Table 84 UAE Meningococcal Vaccines Market, By Type, 2016 - 2027 (USD Million)
Table 85 UAE Meningococcal Vaccines Market, By Brand, 2016 - 2027 (USD Million)
Table 86 UAE Meningococcal Vaccines Market, By Age Group, 2016 - 2027 (USD Million)